These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 34372462)

  • 1. Dynamic Insulin Basal Needs Estimation and Parameters Adjustment in Type 1 Diabetes.
    Berián J; Bravo I; Gardel-Vicente A; Lázaro-Galilea JL; Rigla M
    Sensors (Basel); 2021 Aug; 21(15):. PubMed ID: 34372462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
    Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
    Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An In Silico Head-to-Head Comparison of the Do-It-Yourself Artificial Pancreas Loop and Bio-Inspired Artificial Pancreas Control Algorithms.
    Armiger R; Reddy M; Oliver NS; Georgiou P; Herrero P
    J Diabetes Sci Technol; 2022 Jan; 16(1):29-39. PubMed ID: 34861785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel adaptive basal therapy based on the value and rate of change of blood glucose.
    Wang Y; Percival MW; Dassau E; Zisser HC; Jovanovic L; Doyle FJ
    J Diabetes Sci Technol; 2009 Sep; 3(5):1099-108. PubMed ID: 20144423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Offline Deep Reinforcement Learning and Off-Policy Evaluation for Personalized Basal Insulin Control in Type 1 Diabetes.
    Zhu T; Li K; Georgiou P
    IEEE J Biomed Health Inform; 2023 Oct; 27(10):5087-5098. PubMed ID: 37607154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent closed-loop blood glucose control for people with type 1 diabetes on multiple daily injections.
    Estremera E; Beneyto A; Cabrera A; Contreras I; Vehí J
    Comput Methods Programs Biomed; 2023 Jun; 236():107568. PubMed ID: 37137221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal Glucose Control in Type 1 Diabetes Using Deep Reinforcement Learning: An In Silico Validation.
    Zhu T; Li K; Herrero P; Georgiou P
    IEEE J Biomed Health Inform; 2021 Apr; 25(4):1223-1232. PubMed ID: 32755873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.
    Garcia-Tirado J; Lv D; Corbett JP; Colmegna P; Breton MD
    Comput Methods Programs Biomed; 2021 Nov; 211():106401. PubMed ID: 34560603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.
    Sala-Mira I; Garcia P; Díez JL; Bondia J
    Comput Methods Programs Biomed; 2022 Nov; 226():107061. PubMed ID: 36116400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trial.
    Visentin R; Dalla Man C; Kovatchev B; Cobelli C
    Diabetes Technol Ther; 2014 Jul; 16(7):428-34. PubMed ID: 24571584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic learning algorithm for the MD-logic artificial pancreas system.
    Miller S; Nimri R; Atlas E; Grunberg EA; Phillip M
    Diabetes Technol Ther; 2011 Oct; 13(10):983-90. PubMed ID: 21774690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model-Based Detection and Classification of Insulin Pump Faults and Missed Meal Announcements in Artificial Pancreas Systems for Type 1 Diabetes Therapy.
    Meneghetti L; Facchinetti A; Favero SD
    IEEE Trans Biomed Eng; 2021 Jan; 68(1):170-180. PubMed ID: 32746034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility.
    Cobelli C; Kovatchev B
    J Diabetes Sci Technol; 2023 Nov; 17(6):1493-1505. PubMed ID: 37743740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards the Integration of an Islet-Based Biosensor in Closed-Loop Therapies for Patients With Type 1 Diabetes.
    Olçomendy L; Cassany L; Pirog A; Franco R; Puginier E; Jaffredo M; Gucik-Derigny D; Ríos H; Ferreira de Loza A; Gaitan J; Raoux M; Bornat Y; Catargi B; Lang J; Henry D; Renaud S; Cieslak J
    Front Endocrinol (Lausanne); 2022; 13():795225. PubMed ID: 35528003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Outpatient Clinical Trial of a Full Closed-Loop Artificial Pancreas System in South America.
    Garelli F; Fushimi E; Rosales N; Arambarri D; Mendoza L; Serafini MC; Moscoso-Vásquez M; Stasi M; Duette P; García-Arabehety J; Giunta JN; De Battista H; Sánchez-Peña R; Grosembacher L
    J Diabetes Sci Technol; 2023 Jul; 17(4):1008-1015. PubMed ID: 35549733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.
    Grosman B; Ilany J; Roy A; Kurtz N; Wu D; Parikh N; Voskanyan G; Konvalina N; Mylonas C; Gottlieb R; Kaufman F; Cohen O
    J Diabetes Sci Technol; 2016 May; 10(3):708-13. PubMed ID: 26880389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Trials of an Open-Source Android-Based Artificial Pancreas: A New Paradigm to Test Safety and Efficacy of Do-It-Yourself Systems.
    Toffanin C; Kozak M; Sumnik Z; Cobelli C; Petruzelkova L
    Diabetes Technol Ther; 2020 Feb; 22(2):112-120. PubMed ID: 31769699
    [No Abstract]   [Full Text] [Related]  

  • 20. Automated hybrid closed-loop control with a proportional-integral-derivative based system in adolescents and adults with type 1 diabetes: individualizing settings for optimal performance.
    Ly TT; Weinzimer SA; Maahs DM; Sherr JL; Roy A; Grosman B; Cantwell M; Kurtz N; Carria L; Messer L; von Eyben R; Buckingham BA
    Pediatr Diabetes; 2017 Aug; 18(5):348-355. PubMed ID: 27191182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.